It's one of the most common causes of vision loss, and one of the easiest to overlook. Glaucoma symptoms develop so gradually ...

Developed by Glaukos, the iDose TR (travoprost intraocular implant) 75 mcg is a new, FDA-approved treatment that is designed ...

The use of alpha-blockers for benign prostatic hyperplasia is tied to an increased risk of developing acute angle-closure glaucoma, a study finds.

Trial at 36 Months: 37% reduction in mean intraocular pressure (IOP) in evaluable patients across all dose groups with 95% of patients off all topical IOP-lowering drops100% of evaluable patients ...

Main St. in Fairport will re-open today after months-long closure Donald Trump pardoning Republicans sentenced to prison sparks fury Elon Musk says the AI 'supersonic tsunami' will eliminate desk jobs ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

The U.S. stock market will be open on Monday, Oct. 9, for Columbus Day and Indigenous Peoples Day, but the bond market won’t be which is perhaps more significant for Wall Street. Since the federal ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully integrated, commercial biotechnology ...

Amy is a health reporter and writer with extensive experience covering health conditions, fitness, mental health, and nutrition. She also writes about outdoors and travel. In addition to Health, her ...

A 12-year study of patients with preperimetric glaucoma finds 35.5% convert to primary open-angle glaucoma, often within 5 years.

Machine learning models can predict postoperative hyperopic shift in patients with primary angle-closure glaucoma.

Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia set to launch in NovemberTonmya is the first new FDA-approved ...